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The binding of ricin B-chain to Sepharose, a galactose-based adsorbent, was reversibly inactivated by acetyl- 
ation of tyrosine residues in the absence of lactose. In the presence of lactose, two tyrosine residues were 
protected against modification and the B-chain retained its binding ability. Analyses of tryptic peptides from 
B-chain modified with N-[14C]acetylimidazole in the presence and absence of lactose showed that Tyr-248 
is present in one of the galactose-binding sites. 
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1. INTRODUCTION 
Ricin is a highly toxic glycoprotein isolated from 
the castor bean, Ricinus communis .  It consists of 
two different subunits which are linked by a 
disulphide bond: the A-chain, which catalytically 
inactivates the 60 S ribosomal subunit in 
eukaryotes [1,2], and the B-chain, which contains 
two lactose-binding sites [3-5]. The toxin binds by 
means of the B-chain to galactose-terminating 
oligosaccharides present on the surface of nearly 
all cell types in higher animals. In subsequent steps 
of the intoxication process, the toxin is internalised 
by endocytosis and the A-chain is then 
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translocated, probably across the membrane of the 
endocytic vesicle, into the cytosol where it inhibits 
protein synthesis (reviews [6,7]). Isolated ricin A- 
chain is practically non-toxic since it lacks the lec- 
tin property of the B-chain and so cannot bind to 
and enter cells. 
Tyrosine residues were first implicated in the 
saccharide binding sites of ricin by chemical 
modification. The ability of ricin to bind to 
Sepharose, a copolymer of galactosyl and 
3,6-anhydrogalactosyl residues, was found to be 
diminished reversibly by acetylation of tyrosine 
residues with N-acetylimidazole but binding ability 
was retained if acetylation was performed in the 
presence of a saturating concentration of lactose 
[8,9]. In order to locate the binding site residue(s), 
we synthesized N-[14C]acetylimidazole and used it 
to label tyrosine residues in isolated B-chain. We 
chose to work with the B-chain rather than native 
ricin to facilitate the isolation of peptides contain- 
x4 ing O-[ C]acetyltyrosine residues which are 
unstable in the presence of thiol reagents needed to 
separate the A- and B-chains in the intact toxin. 
In common with ricin, the binding of ricin B- 
chain to Sepharose 4B was reversibly inactivated 
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by acetylation of tyrosine residues in a lactose- 
protectable manner. Using N-[14C]Aclm we were 
able to demonstrate that Tyr-248 was protected 
against modification by the presence of lactose 
suggesting that this tyrosine residue is involved in 
saccharide binding. 
2. MATERIALS AND METHODS 
2.1. Chemical modification 
Ricin B-chain was isolated as described [10] and 
RCA B-chain was isolated by a similar procedure. 
B-chains were modified by adding aliquots of a 
freshly prepared solution of N-Aclm (Sigma, 
Dorset, England) at 1 M in dry DMF to the protein 
solution in 1 ml PBS or PBS containing 0.2 M lac- 
tose at 20°C. Reaction was terminated by rapidly 
desalting the protein solution on a column (10 cm 
x 1.6 cm diameter) of Sephadex G25(M) (Phar- 
macia) equilibrated with PBS. The level of tyrosine 
acetylation was determined spectrophotometrically 
from the increase in absorbance at 278 nm 
resulting from the deacetylation of O- 
acetyltyrosine r sidues on treatment with 0.5 M 
NH2OH [11]. 1/10 vol. of 5 M NH2OH solution 
adjusted to pH 7.0 with NaOH was added to the 
protein solution and to the solution in the 
reference cuvette; deacetylation of modified 
tyrosine residues was complete after 30 min at 
25°C. The concentration of protein solutions was 
itTl °7o calculated after deacetylation assuming ~ZSOnm, 
1 cm = 14 .9  [12] .  
2.2. Radioacetylation 
N-[1-14C]Aclm was prepared by adding 10 mg 
imidazole (BDH, Poole, England), dissolved in 
1 ml dry pyridine, to 0.5 mCi of [1-14C]acetic 
anhydride (112 mCi/mmol) obtained from Amer- 
sham, England. After 20 min at 20°C, one drop of 
acetic anhydride was added to acetylate the im- 
idazole completely. The solvent and by-products 
of the reaction were removed by evaporation under 
vacuum. N-[lac]Aclm was isolated by subliming 
the solid residue at 50°C into a pre-weighed glass 
tube. The product had a specific activity of 
0.8-1.0 mCi/mmol. The number of [14C]acetyl 
groups incorporated into protein was determined 
from the specific activity of the protein after 
desalting. Labelled samples were dissolved in Op- 
tiphase MP (LKB) and counted on an LKB 
Rackbeta liquid scintillation counter. 
2.3. Saccharide binding 
A measure of the extent of inactivation of sac- 
charide binding by ricin B-chain due to acetylation 
was obtained by determining the proportion of 
acetylated protein (estimated from the absorbance 
at 280 nm) which retained affinity for Sepharose 
4B equilibrated with PBS at 4°C. Bound protein 
was eluted from the column with 0.1 M galactose 
in PBS. 
2.4. Peptide isolation and characterisation 
Samples of unmodified and radioacetylated ricin 
B-chains in PBS were denatured by the addition of 
an equal volume of 20 mM sodium phosphate buf- 
fer, pH 6.8, containing 8 M urea. The protein was 
digested in this mixture by adding an aliquot of a 
1 mg/ml solution of TPCK-treated trypsin (Wor- 
thington Enzymes, N J, USA) to give a 1 : 30 ratio 
by weight of proteinase to substrate. After 1 h at 
28°C, the proteinase was inactivated by adding a 
1.2-fold molar excess of soybean trypsin inhibitor 
(Sigma). Tryptic peptides were separated by HPLC 
on a 5/zm particle reversed-phase column (25 cm x 
0.4 cm diameter) of Lichrosorb RP18 (LKB In- 
struments, South Croydon, England) protected by 
an LKB Ultropac precolumn (3 cm x 0.4 cm 
diameter). Samples (0.5 ml) of the tryptic digests 
were subjected to a linear gradient of 0-50°70 (v/v) 
CH3CN HPLC grade S (Rathburn Chemicals, 
Walkerburn, Scotland) in 0.1 M aqueous am- 
monium acetate, pH 7.0, with a flow rate of 
1 ml/min at ambient temperature. Peptide frac- 
tions for amino acid analysis were freeze-dried, 
hydrolysed in 6 M HC1 for 24 h at I10°C and 
analysed using a Beckman 6300 amino acid 
analyser. N-terminal amino acid sequencing was 
performed on an Applied Biosystems 470A se- 
quenator; PTH-amino acids were identified by the 
Applied Biosystems 120A analyser. 
3. RESULTS 
In the absence of lactose, 4.2 (_  0.1) tyrosine 
residues of ricin B-chain were acetylated when the 
B-chain was reacted with 0.1 M N-Aclm at 20°C 
for 15 min or longer. After treatment of acetylated 
ricin B-chain with NHEOH at pH 7 to regenerate 
tyrosine from O-acetyltyrosine residues [131, 
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Fig.1. Reversal of saccharide-binding blockade by 
NH2OH. Ricin B-chain containing 4.20-acetyltyrosine 
residues ( ) was eluted from Sepharose 4B without 
galactose. After treatment with NH2OH at pH 7.0, the 
deacetylated B-chain ( - - - )  was only eluted with 0.1 M 
galactose. 
similar conditions led to the modification of 1.5 
(+ 0.1) tyrosine residues per B-chain subunit and 
inactivation of Sepharose-binding regardless of the 
presence or absence of lactose. 
Amino acids other than tyrosine were also found 
to be modified when B-chain was reacted with N- 
[]4C]Aclm. In order to minimise this stable 
radioacetylation of non-tyrosine residues, the B- 
chain was reacted with a reduced concentration of 
N-[14C]Aclm (5 mM) for 30 min at 20°C. In the 
absence of lactose, 1.7 of the 4.2 acetylatable 
tyrosine residues were modified. Lactose (0.2 M) 
protected 0.9 tyrosine residues against acetylation 
and also reduced the extent of radioacetylation of
other amino acid residues table to NH2OH (table 
1). Tryptic digests of unmodified ricin B-chain and 
B-chains radioacetylated in the presence or absence 
of 0.2 M lactose were analysed by HPLC.  A com- 
binding to Sepharose 4B was restored (fig. 1). This 
demonstrated that loss of binding was due to the 
modification of tyrosine and not of other amino 
acids because residues of e-N-acetyllysine and O- 
acetylserine or O-acetylthreonine are resistant o 
this treatment [13]. Lactose protected 2.0 tyrosine 
residues per B-chain against modification with 
0.1 M N-Aclm for 15 min. More than 85°70 ricin 
B-chain modified in the presence of 0.2 M lactose 
retained the ability to bind to Sepharose 4B as 
compared with only 9070 modified in the absence of 
lactose. Thus, one or more of the tyrosine residues 
that are protected against acetylation appear to be 
involved with saccharide binding. In contrast with 
ricin B-chain, acetylation of RCA B-chain under 
Table 1 
Radioacetylation f tyrosine residues in ricin B-chain a
Modified residues No 0.1 M 
lactose lactose 
Total [~4C]acetyl 2.7 1.3 
O-[]4C]Acetyl-Tyrb 1.7 0.8 
Other [~4C]acetylC 1.0 0.5 
a Ricin B-chain at 1.50 mg/ml modified with 5 mM 
N-[lac]Aclm 
b Determined spectrophotometrically 
c Determined by difference 
Results expressed as mol/mol B-chain 
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Fig.2. Reversed-phase HPLC chromatography of a 
tryptic digest of O-[]4C]acetyl ricin B-chain. (A) 
Unmodified ricin B-chain, (B) B-chain radioacetylated 
in the absence of 0.2 M lactose. Fraction 96 is denoted 
by the solid arrow. 
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parison of HPLC-chromatograms (fig.2) revealed 
the presence of a peptide (fraction 96) in the digest 
of B-chain which had been radioacetylated in the 
absence of lactose that was not present in the digest 
of unmodified B-chain. This peptide was highly 
radiolabelled and was virtually absent from the 
digest of B-chain radioacetylated in the presence of 
0.2 M lactose (fig.3). The specific activity of the 
peptide was consistent with the incorporation of a 
single [14C]acetyl group and its recovery indicated 
that about half of the radiolabel incorporated into 
all tyrosine residues of the B-chain was present in 
this peptide. 
The radiolabelled peptide contained no lysine or 
arginine by amino acid analysis and had a com- 
position which identified it as the C-terminal tryp- 
tic peptide of ricin B-chain, Gln-244-Phe-262 
(table 2). N-terminal amino acid sequencing of the 
complete peptide gave a single detectable sequence 
(not shown) which matched precisely the primary 
structure of the C-terminal region of ricin B-chain 
as determined by direct amino acid sequencing of 
the protein [14] and as deduced from the 
nucleotide sequence of the ricin gene [15,16]. After 
treatment of the [14C]acetyl peptide with NH2OH, 
the peptide was eluted from the reversed-phase col- 
umn at a slightly lower CH3CN concentration, 
consistent with the removal of the hydrophobic 
acetyl group, and was no longer radiolabelled. 
This confirmed that the peptide, which contained 
no acetylatable cysteine, lysine, serine or threonine 
residues, was radioacetylated only on Tyr-248. 
5OOO 
z=,ooo  ¸ 
~- 3000. 
O 
2000' 
uJ 
1000" 
m 
Q 
0 
FRACTION 96 
80 90 100 
FRACTION NUMBER 
Fig.3. Radioactivity of tryptic peptide fractions of O- 
[14C]acetyl ricin B-chains. Ricin B-chain radioacetylated 
in the presence of 0.2 M lactose (open bars) or in the 
absence of lactose (hatched bars). 
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Table 2 
Amino acid analysis of ricin B-chain O-[~4C]acetyl 
peptide 
Residue Predicted a Found 
Asx 2 2.1 
Thr 0 < 0.1 
Ser 0 < 0.1 
Glx 2 2.3 
Pro 3 3.4 
Gly 1 1.1 
Ala 0 < 0.1 
Val 0 < 0.1 
Met 0 < 0.1 
Ile 3 2.8 
Leu 4 4.0 
Tyr 1 0.9 
Phe 1 1.0 
His 1 1.0 
Lys 0 < 0.1 
Arg 0 < 0.1 
a Sequence of ricin B-chain residues 244-262 
4. DISCUSSION 
We synthesized N-[t4C]AcIm in order to label 
and identify tyrosine residues in the lactose- 
binding sites of ricin. O-Acetyltyrosine r sidues are 
labile in the presence of low concentrations of 
nucleophiles and above pH 7 [13] and so the suc- 
cessful application of N-[~4C]AcIm to identify 
modified tyrosine residues depended upon the use 
of mild procedures for generating and isolating 
peptides which avoided loss of O-[14C]acetyl 
groups. For this reason we radioacetylated the 
isolated B-chain which, unlike intact ricin, is 
susceptible to trypsinolysis in the presence of urea 
at pH 7. In common with native ricin, the ability 
of ricin B-chain to bind to Sepharose was inac- 
tivated reversibly by the acetylation of tyrosine 
residues. A maximum of 4 of the 9 tyrosine 
residues present in the B-chain could be acetylated 
using N-Aclm. The presence of 0.2 M lactose pro- 
tected an average of 2 of these acetylatable 
tyrosines against acetylation. As with the intact 
toxin [8,9], B-chain acetylated in the presence of 
lactose retained binding to Sepharose suggesting 
that one or more tyrosine residues are present in 
the saccharide binding sites. 
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By radioacetylating B-chain with N-[~4C]Aclm 
in the presence and absence of lactose and compar- 
ing tryptic digests, we were able to identify a 
tyrosine residue, Tyr-248, that was protected by 
lactose against O-acetylation with this reagent. In 
contrast with ricin B-chain, the number of tyrosine 
residues of RCA B-chain that could be modified 
with N-Aclm was unaffected by the presence of 
lactose in agreement with similar studies on intact 
RCA [17]. The absence of Tyr-248 in the primary 
structure of the RCA B-chain deduced from the 
nucleotide sequence of the RCA gene [18] and by 
direct amino acid sequencing of the protein [19] is 
consistent with this finding. Funatsu and his co- 
workers [20] recently showed that Tyr-248 was 
protected against modification by iodination of in- 
tact ricin. Iodination of ricin also modified B- 
chain tyrosine residues at positions 67, 78 (or 125), 
148 and 176 although these modifications did not 
correlate simply with the presence or absence of 
lactose [20]. This may explain why we were able to 
identify only a single lactose-protectable tyrosine 
residue in the present study. Alternatively, it may 
be that the second lactose-protected residue was 
either Tyr-125 or Tyr-148 which are both expected 
to be present in a single large tryptic peptide which 
we did not isolate in this study. 
Although Tyr-248 was reported to be present in 
the high-affinity lactose-binding site of ricin, its 
iodination apparently did not affect the binding of 
lactose to this site [20] and ricin iodinated in the 
absence of lactose was still able to bind to 
Sepharose [21] in contrast with the present results. 
One explanation for this apparent paradox is that 
the introduction of iodine atoms adjacent o the 
phenolic hydroxyl group of Tyr-248 and the con- 
comitant reduction in pKa of this group does not 
significantly influence the interaction with lactose 
whereas substitution of the hydroxyl group itself 
actually weakens binding. This suggests firstly, 
that Tyr-248 may be located at the periphery of the 
high-affinity binding site, and secondly, that 
bulkier substituents of the hydroxyl group may be 
more effective at inhibiting saccharide binding. 
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